6-132617548-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001033080.1(TAAR2):āc.658A>Gā(p.Thr220Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000558 in 1,613,604 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001033080.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TAAR2 | NM_001033080.1 | c.658A>G | p.Thr220Ala | missense_variant | 2/2 | ENST00000367931.1 | |
TAAR2 | NM_014626.3 | c.523A>G | p.Thr175Ala | missense_variant | 1/1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TAAR2 | ENST00000367931.1 | c.658A>G | p.Thr220Ala | missense_variant | 2/2 | 1 | NM_001033080.1 | A2 | |
TAAR2 | ENST00000275191.2 | c.523A>G | p.Thr175Ala | missense_variant | 1/1 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000277 AC: 42AN: 151786Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000838 AC: 21AN: 250614Hom.: 0 AF XY: 0.0000886 AC XY: 12AN XY: 135464
GnomAD4 exome AF: 0.0000328 AC: 48AN: 1461700Hom.: 0 Cov.: 31 AF XY: 0.0000358 AC XY: 26AN XY: 727158
GnomAD4 genome AF: 0.000276 AC: 42AN: 151904Hom.: 0 Cov.: 32 AF XY: 0.000310 AC XY: 23AN XY: 74232
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2021 | The c.658A>G (p.T220A) alteration is located in exon 2 (coding exon 2) of the TAAR2 gene. This alteration results from a A to G substitution at nucleotide position 658, causing the threonine (T) at amino acid position 220 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at